CPT1-C Antibodies

Santa Cruz Biotechnology features a diverse variety of CPT1-C Antibodies for advanced research in the field of metabolic regulation. CPT1-C Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CPT1-C, or Carnitine Palmitoyltransferase 1C, plays a crucial role in the transport of long-chain fatty acids into the mitochondria for β-oxidation, making it essential for energy metabolism. Its regulation is vital for maintaining metabolic homeostasis, and alterations in CPT1-C expression can be linked to various metabolic disorders. Understanding the function and regulation of CPT1-C is important for developing therapeutic strategies targeting metabolic diseases. CPT1-C research has revealed significant insights into cellular energy utilization and metabolic adaptation. Investigating CPT1-C expression patterns helps identify potential therapeutic targets for metabolic conditions. The role of CPT1-C in fatty acid metabolism continues to be an active area of research, with new findings emerging regularly. Santa Cruz Biotechnology monoclonal antibodies for CPT1-C support researchers worldwide in advancing our understanding of metabolic regulation and disease treatment.